Hygroscopic auxiliary material-based solid preparation

A solid preparation and hygroscopic technology, which is applied in the field of solid preparations based on easily hygroscopic excipients, can solve the problems of simvastatin raw materials on thermal instability, drug stability, acceleration, etc.

A solid preparation and hygroscopic technology, which is applied in the field of solid preparations based on easily hygroscopic excipients, can solve the problems of simvastatin raw materials on thermal instability, drug stability, acceleration, etc.

CN101978953AInactive Publication Date: 2011-02-23SHANGHAI JIAO TONG UNIV
10 Cites 14 Cited by

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] The components of this example and their mass percentages are: 5% simvastatin, 0.5% BHA, 60.5% lactose, 28% microcrystalline cellulose, 5% croscarmellose sodium and 1% magnesium stearate .

[0020] Wherein: the amount of simvastatin is 5mg, 10mg, 20mg or 40mg.

[0021] The preparation method of this embodiment comprises the following steps:

[0022] (1) Weigh BHA into a glass mortar, gradually add lactose and mix evenly by doubling the grinding method, and pass through a 60-mesh sieve to obtain the mixture β‘ ;

[0023] (2) Then weigh the simvastatin of the prescribed amount and put it into a glass mortar, then add the above-mentioned mixture β‘  and mix by double grinding method to obtain the mixture β‘‘;

[0024] (3) Weigh lactose equal to the above-mentioned mixture β‘‘, mix with the mixture β‘‘ evenly, and pass through a 20-mesh sieve to obtain the mixture β‘’;

[0025] (4) Mix the mixture β‘’ with the remaining lactose, microcrystalline cellulose, and croscarmellose sodium in...

Embodiment 2

[0027] The components and their mass percentages in this example are: 5.1% simvastatin, 0.3% BHA, 59.7% lactose, 30.8% microcrystalline cellulose, 5.2% sorbitol and 0.9% magnesium stearate.

[0028] Wherein: the amount of simvastatin is 5mg, 10mg, 20mg or 40mg.

[0029] The preparation method of this embodiment comprises the following steps:

[0030] (1) Weigh BHA into a glass mortar, gradually add lactose and mix evenly by doubling the grinding method, and pass through a 60-mesh sieve to obtain the mixture β‘ ;

[0031] (2) Then weigh the simvastatin of the prescribed amount and put it into a glass mortar, then add the above-mentioned mixture β‘  and mix by double grinding method to obtain the mixture β‘‘;

[0032] (3) Weigh lactose equal to the above-mentioned mixture β‘‘, mix with the mixture β‘‘ evenly, and pass through a 20-mesh sieve to obtain the mixture β‘’;

[0033] (4) Mix the mixture β‘’ with the remaining lactose, microcrystalline cellulose, and sorbitol in a mixer, then add m...

Embodiment 3

[0035] The components and their mass percentages of this example are: 4.8% simvastatin, 0.4% BHA, 58.6% lactose, 30% microcrystalline cellulose, 30% microcrystalline cellulose, 5.2% citric acid and magnesium stearate 1 %.

[0036] Wherein: the amount of simvastatin is 5mg, 10mg, 20mg or 40mg.

[0037] The preparation method of this embodiment comprises the following steps:

[0038] (1) Weigh BHA into a glass mortar, gradually add lactose and mix evenly by doubling the grinding method, and pass through a 60-mesh sieve to obtain the mixture β‘ ;

[0039] (2) Then weigh the simvastatin of the prescribed amount and put it into a glass mortar, then add the above-mentioned mixture β‘  and mix by double grinding method to obtain the mixture β‘‘;

[0040] (3) Weigh lactose equal to the above-mentioned mixture β‘‘, mix with the mixture β‘‘ evenly, and pass through a 20-mesh sieve to obtain the mixture β‘’;

[0041] (4) Mix the mixture β‘’ with the remaining lactose, microcrystalline cellulose, an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a hydroscopic auxiliary material-based solid preparation, which belongs to the technical field of medicament preparation. The solid preparation comprises the following components: 1 to 10 percent of active ingredient, 0.1 to 60 percent of hydroscopic auxiliary material, 0.1 to 2.0 percent of antioxidant, 40 to 75 percent of excipient, 2 to 10 percent of disintegrating agent, 1 to 10 percent of adhesive, and 0.5 to 3 percent of lubricant. The problem can be solved by utilizing a method of adding the hydroscopic auxiliary material, and the contact between a hydroscopic medicament and moisture is reduced so as to reduce the hydrolysis of the hydrolytic medicament in the solid preparation.

Description

technical field [0001] The invention relates to a preparation in the technical field of pharmaceutical preparation, in particular to a solid preparation based on a hygroscopic auxiliary material. Background technique [0002] The basic requirements of pharmaceutical preparations should be safe, effective and stable. Stability refers to the stability of a drug in vitro. If the drug decomposes and deteriorates, it will not only reduce the efficacy of the drug, but some drugs may even produce toxic and side effects. Therefore, the stability of the drug preparation is very important to ensure the safety and effectiveness of the drug preparation. Drugs have different degradation reactions due to different chemical structures. Hydrolysis and oxidation are the two main pathways for drug degradation. Other reactions such as isomerization, polymerization, and decarboxylation also occur in some drugs. [0003] Hydrolysis is the main way of drug degradation, and the drugs that belon...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
23 Feb 2011
Publication
CN101978953A
IPC
A61K9/48; A61K47/36; A61K47/38; A61K47/34; A61K47/10; A61K47/12; A61K9/16; A61K47/42; A61K47/44; A61K9/20; A61K9/14; A61K47/32; A61K47/26; A61K47/14
Inventors
ιƒ­εœ£θ£; ι™ˆδΌŸε³¦